Stavropoulos Andreas, Sculean Anton, Karring Thorkild
Department of Periodontology and Oral Gerontology, Royal Dental College, Faculty of Health Sciences, University of Aarhus, Vennelyst Boulevard 9, 8000 Aarhus, Denmark.
Clin Oral Investig. 2004 Dec;8(4):226-32. doi: 10.1007/s00784-004-0277-0. Epub 2004 Aug 3.
The objectives of this study were to evaluate the results of guided tissue regeneration (GTR) treatment of intrabony defects with two kinds of bioresorbable membranes, with deproteinized bovine bone (Bio-Oss) used as an adjunct. Twenty-eight patients with at least one intrabony defect with a probing pocket depth (PPD) >/=7 mm and radiographic evidence of an intrabony component (IC) >/=4 mm were randomly treated with either a polylactic/polyglycolic (PLA/PGA) acid copolymer or a collagen bioresorbable membrane combined with Bio-Oss implantation. Immediately prior to surgery (baseline) and after 1 year, the following parameters were recorded: (1) PPD, (2) gingival recession (REC), (3) probing attachment level (PAL), (4) presence/absence of plaque (PI), and (5) presence/absence of bleeding on probing (BOP). Occurrence of membrane exposure during healing and the smoking habits of the patients were also recorded. Statistical analysis was carried out using chi(2) -tests and t-tests. There were no significant differences between the two membrane groups regarding the clinical parameters at baseline. Statistically significant clinical improvements (PAL gains, reduced PPDs) were observed 1 year after treatment in both groups. There were no significant differences, however, between the PLA/PGA and the collagen membrane groups regarding any of the evaluated parameters (mean PAL gain: 2.9 mm vs 3.9 mm; mean residual PPD: 4.8 mm vs 4.1 mm, respectively). The membrane material per se does not seem to be a critical factor for the outcome of GTR treatment of intrabony defects with bioresorbable membranes.
本研究的目的是评估使用两种生物可吸收膜治疗骨内缺损的引导组织再生(GTR)效果,并使用脱蛋白牛骨(Bio-Oss)作为辅助材料。28例至少有一个骨内缺损且探诊袋深度(PPD)≥7mm、骨内成分(IC)影像学证据≥4mm的患者,被随机分为接受聚乳酸/聚乙醇酸(PLA/PGA)共聚物或胶原生物可吸收膜联合Bio-Oss植入治疗。在手术前即刻(基线)和1年后,记录以下参数:(1)PPD,(2)牙龈退缩(REC),(3)探诊附着水平(PAL),(4)菌斑存在与否(PI),以及(5)探诊出血存在与否(BOP)。还记录了愈合过程中膜暴露的发生情况以及患者的吸烟习惯。使用卡方检验和t检验进行统计分析。两组在基线时的临床参数方面无显著差异。两组在治疗1年后均观察到统计学上显著的临床改善(PAL增加,PPD降低)。然而,在任何评估参数方面,PLA/PGA组和胶原膜组之间均无显著差异(平均PAL增加:分别为2.9mm对3.9mm;平均残余PPD:分别为4.8mm对4.1mm)。对于使用生物可吸收膜治疗骨内缺损的GTR结果而言,膜材料本身似乎不是关键因素。